Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

French Pharmacopoeia

Characteristics for food-grade paraffins Codex test French pharmacopoeia... [Pg.311]

Caujolle, F. Vegetable essences in french pharmacopoeia. Indian Pharm. 1954, 10 (3). [Pg.972]

The regulatory authority in Mexico is the Direccion General de Control de Insumos para la Salud (DIGE-CIS). The Health Secretariat issues pharmaceutical registration. Safety and efficacy must be proven by phase III clinical trials in Mexico to register drugs that are new to the Mexican market. All major pharmacopeia (/ntemahona/ Pharmacopoeia, US Pharmacopeia, British Pharmacopoeia, French Pharmacopoeia, Swiss Pharmacopoeia, European Pharmacopoeia, and Japanese Pharmacopoeia) are acceptable in Mexico. [Pg.1983]

The National Pharmacopoeia Commission is assigned to the preparation and editing of the French Pharmacopoeia under the authorisation of the Minister of Health (Article R 5002-R 5006 of the CSP). [Pg.127]

Medicinal plants No registration is required. In general eill plants included in the European, British, American emd French Pharmacopoeia are permitted for sale in pharmacies. Some plants are prohibited for sale these are listed separately. [Pg.232]

Available products include tea, 1 5 tincture in 45% alcohol, 1 1 liquid extract in 25% alcohol (6), and capsules of 250,455, and 510 mg. The French Pharmacopoeia requires 45% ethanol for the fluid extract and 60% ethanol for the tincture (8). It is recommended that 0.5-1 mL of liquid extract or 1-2 mL of tincture be taken three times a day (6). The tea is made from 0.3-1 g of dried berries infused in hot water and taken three times a day (4,6). A typical therapeutic dose of extract, standardized to contain 1.8% vitexin-4 rhamno-side, is 100-250 mg three times daily. A standardized extract containing 18% procyanidolic oligomers (oligomeric procyanidns) is dosed at 250-500 mg daily (9). [Pg.204]

The 1746 London Pharmacopoeia was the last in which Mithridatium and Galene appear they were absent from the 1788 edition. The Edinburgh Pharmacopoeia, first published in 1699, dropped Mithridatium and Galene from the 1756 edition. Not all western European countries were so quick to expunge these formulations, for Galene with its vipers appears in the German Pharmacopoeia of 1872 and in the French Pharmacopoeia of 1884. [Pg.588]

With the disappearance of Mithridatium from the French Pharmacopoeia, the long-used complex remedy attributable to an experimental toxicologist from the first century bc came to an end. Perhaps in the final analysis, the contribution of Mithridatium and theriac to modem medicine was that concerns about their quality stimulated the earliest concepts of medicines regulation. [Pg.588]

DCF (Denominations Communes Frangaises) (Secretariat of the French Pharmacopoeia Commission at the Drug Agency, Direction des Laboratoires et des Condoles, Unite Pharmacopee, 145-147, Boulevard Anatole France, 93200 Saint-Denis, France). [Pg.874]

Sixteen-membered macrolides are represented clinically by spiramycin. It is listed in the French Pharmacopoeia (but not in the United States). It has a similar antibacterial spectrum, but claims higher MIC. [Pg.257]

Homeopathy relies for the most part on the vegetable kingdom with, as the basic rule, a preference for fresh,wild plants, collected in their natural habit where they grow optimally,far from the sources of pollution. The harvesting is carried out according to written instructions drawn up by the manufacturer, conformity with the French Pharmacopoeia (10th edition). [Pg.393]

Preparations from Aconitum plants have been used in traditional Chinese medicine as cardiotonics, febrifuges, sedatives, and antirheumatics [22]. They have also been used in traditional medicine of some ex-USSR countries for the treatment of cancer, rheumatism, etc. [18, 23]. Aconitum plants were introduced in the medicine of European countries in the nineteenth century. Leaves and roots of Aconitum and aconitine powder were included in the British Pharmaceutical Codex (01911) [24], French Pharmacopoeia (9th edition) [25], and USSR Pharmacopoeia (8th edition) [26] and were applied to relieve neuralgic pain, especially in the face, to allay the pain of sciatica and acute rheumatism. Because of extreme toxicity, aconitine was replaced later by less-toxic anti-inflammatory and analgesic agents in European countries presently, the use of Aconitum plants is limited to the homeopathic medicine [27, 28]. On the contrary, in many Asiatic countries, aconitine-containing plants still remain one of the most popular remedies, and more and more new, naturally occurring or semisynthetic molecules from Aconitum species are introduced in medical use. Eor example, lappaconitine found in several Aconitum species, bulleyaconitine isolated from A. bulleyanum, and crassicauline A isolated from A. crassicaule were introduced in the official Chinese medicine for the treatment of chronic pain, rheumatoid arthritis, and for local anesthesia [29, 30]. [Pg.1507]

Substance is monographed only in French Pharmacopoeia, 10th edition,... [Pg.396]

Regulatory Status. Undetermined in the United States official in the French pharmacopoeia as early as 1884 official in Indian pharmacopoeia also once official in the Dutch, Mexican, Spanish, and Venezuelan pharmacopoeias. [Pg.341]

Regulatory U.S., Japan, Europe, French pharmacopoeia compliance DMF no. 5849... [Pg.631]


See other pages where French Pharmacopoeia is mentioned: [Pg.313]    [Pg.51]    [Pg.213]    [Pg.38]    [Pg.137]    [Pg.305]    [Pg.422]    [Pg.395]    [Pg.251]    [Pg.329]    [Pg.200]    [Pg.296]    [Pg.210]    [Pg.9]    [Pg.433]    [Pg.55]    [Pg.353]    [Pg.3090]   
See also in sourсe #XX -- [ Pg.353 ]




SEARCH



French

© 2024 chempedia.info